Abstract

IMPACT OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL INDUSTRY

Vilas Nikam*, Shaikh Moh. Zahed, Shubham Akolkar, Sabafarin H. Shaikh, Rohini A. Satdive, Renuka K. Sagane

Abstract

The pharmaceutical sector is experiencing significant advancements with the integration of artificial intelligence (AI). Many pharmaceutical companies are adopting this technology to enhance the drug discovery and development phases, which will facilitate various research-oriented projects related to novel drug delivery approaches. The speed at which AI operates can reduce the time lag between the development of a drug product and its commercialization. Additionally, AI is being utilized in clinical trials to generate and interpret data collected from patients. In this article, we will discuss the various roles of artificial intelligence in drug development, tablet manufacturing, the design of antibiotic peptides, and clinical research. This overview highlights the significant impact that artificial intelligence has on the pharmaceutical industry. One of the most important advantages of AI is its ability to reduce costs associated with drug development. This, in turn, enhances returns on investment and may lead to lower prices for end users. The present review article explores topics such as drug discovery, diagnosis, prediction of new treatments, the development of novel peptides from natural foods, treatment and management of rare diseases, drug adherence, and dosage challenges related to the adoption of artificial intelligence in the pharmaceutical industry.

Keywords: Artificial intelligence and machine learning are transforming the pharmaceutical industry, particularly in drug discovery, manufacturing, and clinical trials.